Form 4: Doximity CFO Receives Significant RSU Grant
Insider Transaction Report
Doximity's Chief Financial Officer, Anna Bryson, was granted 152,258 restricted stock units, with a portion withheld for tax obligations.
Summary
- Anna Bryson, Chief Financial Officer of Doximity, Inc. (DOCS), was granted 152,258 restricted stock units (RSUs) on February 15, 2026.
- These RSUs vest in equal quarterly installments over 12 months, beginning on February 15, 2026, contingent on her continued service.
- Concurrently, 11,381 shares of Class A Common Stock were disposed of at a price of $25.02 per share to satisfy tax withholding obligations related to previously vested RSUs.
- The disposition for tax purposes was mandated by an issuer election and was not a discretionary trade by Ms. Bryson.
- Following these transactions, Anna Bryson beneficially owns 505,549 shares of Class A Common Stock directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event, reflecting standard executive compensation and retention efforts, which generally signals stability in leadership.
Positives
- The grant of 152,258 restricted stock units to the Chief Financial Officer indicates continued commitment to retaining key executive talent.
- The vesting schedule over 12 months provides an incentive for the CFO's continued service and alignment with long-term company performance.
Negatives
- No discretionary sales were made by the CFO; the disposition of 11,381 shares was solely for tax withholding purposes, which is a standard compensation event.
Future Outlook
The granted restricted stock units will vest in equal quarterly installments over 12 months, beginning February 15, 2026, subject to the CFO's continued employment.
Management Comments
- The RSU grant is part of the company's compensation structure, designed to align executive interests with shareholder value and ensure retention.
Industry Context
StockSavvy.ai notes that RSU grants are a prevalent form of executive compensation in the technology and healthcare technology sectors, serving as a key tool for talent retention and performance alignment. This grant to Doximity's CFO is consistent with industry practices for incentivizing leadership.
Comparison to Industry Standards
- RSU grants are a standard component of executive compensation packages across the tech and healthcare tech industries, similar to practices at companies like Teladoc Health (TDOC) or Veeva Systems (VEEV).
- The vesting schedule of quarterly installments over 12 months is a common short-to-medium term incentive structure, comparable to those seen in many publicly traded software and service companies.
- The disposition of shares for tax withholding is a routine, non-discretionary event associated with RSU vesting, aligning with standard tax compliance procedures for equity compensation in the U.S. market.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | N/A (confirmed in role) | Anna Bryson | N/A | N/A (filing confirms existing role and compensation) |
Related Party Transactions
- The grant of 152,258 restricted stock units to Anna Bryson, the Chief Financial Officer, constitutes a transaction between the company and a key executive.
Stakeholder Impact
- Shareholders gain transparency into executive compensation practices and the alignment of management's interests with the company's long-term performance through equity grants.
- Employees may view this as a positive signal regarding the company's commitment to its leadership team.
Next Steps
- The granted RSUs will continue to vest in quarterly installments over the next 12 months, starting February 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 02/15/2026 | Date of RSU grant and tax withholding transaction. |
| 02/18/2026 | Date the Form 4 was signed. |
Keywords
Doximity, DOCS, Anna Bryson, CFO, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.